Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Terlipressin in Japanese Patients with Hepatorenal Syndrome Type 1
NCT01373606Phase 2Completed
- Sponsor
- Ferring Pharmaceuticals
- Start
- Nov 2007
- Primary completion
- Mar 2009
- Modality
- Peptides, Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of terlipressin in hepatorenal syndrome type 1 (HRS-1), sponsored by Ferring Pharmaceuticals. Started Nov 2007; status: completed.
02
Drugs
terlipressin
03
Conditions
hepatorenal syndrome type 1 (HRS-1)
Beyond the preview
Go deeper on NCT01373606.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01373606.